EP3355948A4 - Zusammensetzung zur weichgewebeverstärkung zur bereitstellung von schutz vor infektionen - Google Patents

Zusammensetzung zur weichgewebeverstärkung zur bereitstellung von schutz vor infektionen Download PDF

Info

Publication number
EP3355948A4
EP3355948A4 EP16852758.8A EP16852758A EP3355948A4 EP 3355948 A4 EP3355948 A4 EP 3355948A4 EP 16852758 A EP16852758 A EP 16852758A EP 3355948 A4 EP3355948 A4 EP 3355948A4
Authority
EP
European Patent Office
Prior art keywords
composition
protection against
soft tissues
against infection
increasing soft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16852758.8A
Other languages
English (en)
French (fr)
Other versions
EP3355948A1 (de
Inventor
Robert Diluccio
Paul LORENC
Randy MILBY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2016/054926 external-priority patent/WO2017059321A1/en
Publication of EP3355948A1 publication Critical patent/EP3355948A1/de
Publication of EP3355948A4 publication Critical patent/EP3355948A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16852758.8A 2015-10-02 2016-09-30 Zusammensetzung zur weichgewebeverstärkung zur bereitstellung von schutz vor infektionen Withdrawn EP3355948A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562236463P 2015-10-02 2015-10-02
PCT/US2016/054926 WO2017059321A1 (en) 2015-10-02 2016-09-30 Composition for soft tissue augmentation providing protection from infection

Publications (2)

Publication Number Publication Date
EP3355948A1 EP3355948A1 (de) 2018-08-08
EP3355948A4 true EP3355948A4 (de) 2019-06-12

Family

ID=62748551

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16852758.8A Withdrawn EP3355948A4 (de) 2015-10-02 2016-09-30 Zusammensetzung zur weichgewebeverstärkung zur bereitstellung von schutz vor infektionen

Country Status (1)

Country Link
EP (1) EP3355948A4 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104026A1 (en) * 2001-08-27 2003-06-05 Wironen John F. Processed soft tissue for topical or internal application
US20040037810A1 (en) * 2000-05-03 2004-02-26 Dennis Von Heimburg Biomaterials comprised of preadipocyte cells for soft tissue repair

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040037810A1 (en) * 2000-05-03 2004-02-26 Dennis Von Heimburg Biomaterials comprised of preadipocyte cells for soft tissue repair
US20030104026A1 (en) * 2001-08-27 2003-06-05 Wironen John F. Processed soft tissue for topical or internal application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SAMUEL J. FALCONE ET AL: "Crosslinked hyaluronic acid dermal fillers: A comparison of rheological properties", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, vol. 87A, no. 1, 1 October 2008 (2008-10-01), pages 264 - 271, XP055203615, ISSN: 1549-3296, DOI: 10.1002/jbm.a.31675 *
See also references of WO2017059321A1 *

Also Published As

Publication number Publication date
EP3355948A1 (de) 2018-08-08

Similar Documents

Publication Publication Date Title
EP3328403A4 (de) Exosome zusammensetzungen und verwendung davon zur weichgewebereparatur
MA41901A (fr) Compositions contenant de l'ibrutinib
EP3356485A4 (de) An polymersubstrate gebundene hydrogelzusammensetzungen
EP3720458A4 (de) Verfahren und zusammensetzungen zur verhinderung von mikrobieller infektion
EP3362467A4 (de) Immunogene zusammensetzungen gegen porzines circovirus typ 3 und verfahren zur herstellung und verwendung davon
EP3515467C0 (de) Ophthalmische zusammensetzungen mit ciclosporin
EP3297455A4 (de) Glycosidzusammensetzungen
IL285232A (en) Preparations containing oleandrin for the treatment of viral infection
EP3324739A4 (de) Antimikrobielle zusammensetzungen für chirurgische anwendungen
DK3600363T3 (da) Sammensætninger omfattende bakteriestammer
EP2828241A4 (de) Zusammensetzungen und verfahren zur hemmung von cathepsinen
EP3530722A4 (de) Reinigungsmittelzusammensetzung
PL3573620T3 (pl) Kompozycje do leczenia nadciśnienia
EP3704757A4 (de) Elektrolytzusammensetzung
MA50787A (fr) Compositions fongicides
EP3397252A4 (de) Körperpflegezusammensetzungen
EP3250553A4 (de) Zusammensetzungen und verfahren zur hemmung viraler infektionen
DK3452093T3 (da) Ophthalmiske sammensætninger
GB201707462D0 (en) Ocular compositions
EP3302061A4 (de) Harnstoffzusammensetzungen mit verlängerter freisetzung
DK3638271T3 (da) Sammensætninger omfattende bakteriestammer
EP3733177A4 (de) Zusammensetzung für hornhautschutz
BR112017017317A2 (pt) Ácido (2s,4r)-5-(5'-cloro-2'-fluorobifenil-4-il)-4- (etoxioxalilamino)-2-hidroximetil-2-metilpentanóico como inibidor de neprilisina
FR3020758B1 (fr) Composition pour ameliorer l'hygiene buco-dentaire
PL3280401T3 (pl) Kompozycje do leczenia i/lub zapobiegania martwicy komórek lub tkanek specjalnie ukierunkowane na katepsynę C i/lub CELA1 i/lub CELA3A i/lub strukturalnie związane z nimi enzymy

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190510

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/54 20060101ALI20190506BHEP

Ipc: A61L 27/58 20060101AFI20190506BHEP

Ipc: A61L 27/20 20060101ALI20190506BHEP

Ipc: A61L 27/38 20060101ALI20190506BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200331

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20221103